AIM ImmunoTech Inc (STU:HXB2)
€ 0.356 0.002 (0.56%) Market Cap: 18.26 Mil Enterprise Value: 11.88 Mil PE Ratio: 0 PB Ratio: 4.70 GF Score: 40/100

Q4 2022 AIM ImmunoTech Inc Earnings Call Transcript

Apr 03, 2023 / 12:30PM GMT
Release Date Price: €0.39 (+1.38%)
Operator

Hello, and welcome to the AIM ImmunoTech inaugural FY 2022 update conference call and webcast. (Operator Instructions) Note that this webcast is being recorded at the company's request, and a replay will be made available on the company's website following the end of the event.

At this time, I'd like to remind our listeners that remarks made during this webcast may state management's intentions, beliefs, expectations, or future projections. These are forward-looking statements and involve risks and uncertainties.

Forward-looking statements on this call are made pursuant to the Safe Harbor provisions of the federal securities laws and are based on AIM ImmunoTech's current expectations, and actual results could differ materially.

As a result, you should not place undue reliance on any forward-looking statements. Some of the factors that could cause actual results to differ materially from these contemplated by such forward-looking statements are discussed in the periodic reports AIM ImmunoTech files with the Securities and Exchange Commission. These documents are available in the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot